Citation: Yaodong You, Kun Zhu, Jie Wang, Qi Liang, Wen Li, Lin Wang, Baojun Guo, Jing Zhou, Xuanlin Feng, Jianyou Shi. ROCK inhibitor: Focus on recent updates[J]. Chinese Chemical Letters, ;2023, 34(12): 108336. doi: 10.1016/j.cclet.2023.108336 shu

ROCK inhibitor: Focus on recent updates

Yaodong You ^{a, b, 1} ,
Kun Zhu ^{a, 1} ,
Jie Wang ^c ,
Qi Liang ^d ,
Wen Li ^a ,
Lin Wang ^e ,
Baojun Guo ^a ,
Jing Zhou ^a ,
Xuanlin Feng ^{f, *,} ,
Jianyou Shi ^{g, *,}

a.
Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China
b.
TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Chengdu 610072, China
c.
Guizhou University of Traditional Chinese Medicine, Guiyang 550002, China
d.
College of Medicine, Southwest Jiaotong Unive, Chengdu 610031, China
e.
College of Food and Bioengineering, Xihua University, Chengdu 610039, China
f.
Department of Emergency Intensive Care Unit, Sichuan Academy of Medical Sciences & Sichuan Province People's Hospital, Chengdu 610072, China
g.
Department of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology, Chengdu 610072, China

23376592@qq.com

shijianyoude@126.com

Received Date: 5 January 2023
Revised Date: 8 March 2023
Accepted Date: 12 March 2023
Available Online: 15 March 2023

Figures(12)

Rho-associated coiled-coil-containing protein kinase (ROCK) belongs to the serine-threonine family, and ROCK is involved in a variety of biological processes including cell migration, adhesion, proliferation and differentiation through phosphorylation of different downstream substrates. The aberrant activation of ROCK is associated with the pathological conditions in different systems including various diseases, including cancer, neurological diseases, inflammation, cardiovascular diseases and glaucoma. Therefore, the ROCK inhibitors have potential applicability for treating the aforementioned diseases. Four small molecule ROCK inhibitors have been approved for clinical use: fasudil, ripasudil, netarsudil and belumosudil. In recent years, more small molecule ROCK inhibitors have been identified. This paper reviews the ROCK inhibitors reported in past seven years. We mainly focused on the summarization of the structure–activity relationships, inhibitory efficacy, pharmacological mechanisms and the relevant clinical studies of the reported ROCK inhibitors. Besides the small molecular inhibitors, the peptides and biological extracts which exhibit ROCK inhibitory effects are also included. We also provide suggestions for the future development of the potent ROCK inhibitors.
- ROCK-Ⅰ,
- ROCK-Ⅱ,
- ROCK inhibitor,
- ROCK signaling pathway,
- Structure–activity relationship,
- Pharmacological activity
1. [1]
  J. Hu, P. Zhu, Y. Li, Y. Chen, Chin. Chem. Lett. 29 (2018) 1043-1050. doi: 10.1016/j.cclet.2018.05.035
2. [2]
  J. Shi, L. Wei, Arch. Immunol. Ther. Exp. 70 (2022) 4. doi: 10.1007/s00005-022-00642-z
3. [3]
  T. Ushijima, N. Fujimoto, S. Matsuyama, et al., J. Biol. Chem. 293 (2018) 148-162. doi: 10.1074/jbc.m117.813931
4. [4]
  N. Karimi, F. Bayram Catak, E. Arslan, et al., Int. Immunopharmacol. 113 (2022) 109445. doi: 10.1016/j.intimp.2022.109445
5. [5]
  D.R. Thal, S.O. Tome, Brain Res. Bull. 190 (2022) 204-217. doi: 10.1016/j.brainresbull.2022.10.006
6. [6]
  C. Hu, H. Zhou, Y. Liu, et al., Int. J. Oncol. 55 (2019) 833-844.
7. [7]
  Y. Hiroi, K. Noma, H.H. Kim, et al., Circ. J. 82 (2018) 1195-1204. doi: 10.1253/circj.CJ-17-0732
8. [8]
  L. Julian, M.F. Olson, Small GTPases 5 (2014) e29846. doi: 10.4161/sgtp.29846
9. [9]
  W. Chen, M.S. Nyuydzefe, J.M. Weiss, et al., Sci. Rep. 8 (2018) 16636. doi: 10.1038/s41598-018-35109-9
10. [10]
  N. Zhou, J.J. Lee, S. Stoll, et al., Cell. Physiol. Biochem. 44 (2017) 701-715. doi: 10.1159/000485284
11. [11]
  E. Berrino, C.T. Supuran, Expert Opin. Ther. Pat. 29 (2019) 817-827. doi: 10.1080/13543776.2019.1670812
12. [12]
  C. Vennin, V.T. Chin, S.C. Warren, et al., Sci. Transl. Med. 9 (2017) eaai8504. doi: 10.1126/scitranslmed.aai8504
13. [13]
  L. Deng, G. Li, R. Li, et al., Cancer Biol. Ther. 9 (2010) 875-884. doi: 10.4161/cbt.9.11.11634
14. [14]
  I. Hinsenkamp, S. Schulz, M. Roscher, et al., Neoplasia 18 (2016) 500-511. doi: 10.1016/j.neo.2016.07.002
15. [15]
  J.M. Thompson, Q.H. Nguyen, M. Singh, et al., Oncogene 36 (2017) 1080-1089. doi: 10.1038/onc.2016.272
16. [16]
  Y. Xia, X. Cai, J. Fan, et al., Anticancer Drugs 28 (2017) 514-521. doi: 10.1097/CAD.0000000000000490
17. [17]
  Z.H. Wang, D. Zhu, S. Xie, et al., J. Cardiovasc. Pharmacol. 70 (2017) 102-109. doi: 10.1097/FJC.0000000000000496
18. [18]
  N.T. Abdali, A.H. Yaseen, E. Said, T.M. Ibrahim, Naunyn. Schmiedebergs Arch. Pharmacol. 390 (2017) 409-422. doi: 10.1007/s00210-017-1343-x
19. [19]
  T.L. Montagnoli, J.S. da Silva, S.Z. Sudo, et al., Cells 10 (2021) 1648. doi: 10.3390/cells10071648
20. [20]
  D. Xueyang, M. Zhanqiang, M. Chunhua, H. Kun, Oncotarget 7 (2016) 78764-78772. doi: 10.18632/oncotarget.12853
21. [21]
  L. Qi, Y.G. Tang, L. Wang, et al., J. Neurol. Sci. 370 (2016) 21-26. doi: 10.1016/j.jns.2016.08.061
22. [22]
  J.L. Labandeira-Garcia, A.I. Rodriguez-Perez, B. Villar-Cheda, et al., Neuroscientist 21 (2015) 616-629. doi: 10.1177/1073858414554954
23. [23]
  J. Han, Y. Zhao, Y. Zhang, et al., Front. Pharmacol. 9 (2018) 87. doi: 10.3389/fphar.2018.00087
24. [24]
  R. Abbasgholizadeh, H. Zhang, J.W. Craft Jr., et al., Exp. Biol. Med. 244 (2019) 940-951. doi: 10.1177/1535370219849581
25. [25]
  L. Song, C. Zhu, W. Zheng, et al., Comput. Biol. Chem. 87 (2020) 107314. doi: 10.1016/j.compbiolchem.2020.107314
26. [26]
  S.P. Davies, H. Reddy, M. Caivano, P. Cohen, Biochem. J. 351 (2000) 95-105. doi: 10.1042/bj3510095
27. [27]
  Y. Feng, P.V. LoGrasso, O. Defert, R. Li, J. Med. Chem. 59 (2016) 2269-2300. doi: 10.1021/acs.jmedchem.5b00683
28. [28]
  T. Landry, D. Shookster, H. Huang, Front. Endocrinol. 11 (2020) 622581.
29. [29]
  L. Huang, F. Dai, L. Tang, et al., Cell. Physiol. Biochem. 49 (2018) 565-577. doi: 10.1159/000492994
30. [30]
  J. Du, J. Guo, D. Kang, et al., Chin. Chem. Lett. 31 (2020) 1695-1708. doi: 10.1016/j.cclet.2020.03.028
31. [31]
  S. Ghosh, S. Keretsu, S.J. Cho, PeerJ 9 (2021) e11951. doi: 10.7717/peerj.11951
32. [32]
  B. Bayel Secinti, G. Tatar, T. Taskin Tok, J. Biomol. Struct. Dyn. 37 (2019) 2457-2463. doi: 10.1080/07391102.2018.1491420
33. [33]
  H. Chen, S. Li, Y. Hu, et al., Comb. Chem. High Throughput Screen. 19 (2016) 36-50. doi: 10.2174/1386207319666151203001946
34. [34]
  S. Ansar, U. Vetrivel, J. Biomol. Struct. Dyn. 40 (2022) 7450-7468. doi: 10.1080/07391102.2021.1898470
35. [35]
  A.A. Sadybekov, A.V. Sadybekov, Y. Liu, et al., Nature 601 (2022) 452-459. doi: 10.1038/s41586-021-04220-9
36. [36]
  J.C. Koch, L. Tatenhorst, A.E. Roser, et al., Pharmacol. Ther. 189 (2018) 1-21. doi: 10.1016/j.pharmthera.2018.03.008
37. [37]
  C.M. Chong, M.T. Kou, P. Pan, et al., Mol. Biosyst. 12 (2016) 2713-2721. doi: 10.1039/C6MB00343E
38. [38]
  M. Rosen Kenneth, D. Abbinanti Matthew, J. Ruschel, et al., BioAxone BioSciences Inc. Patent, US2020199105 (A1), 2020.
39. [39]
  L. McKerracher, R. Shenkar, M. Abbinanti, et al., Transl. Stroke Res. 11 (2020) 365-376. doi: 10.1007/s12975-019-00725-8
40. [40]
  J. Liang, M. Tang, L. Wang, et al., Chem. Biol. Drug Des. 98 (2021) 1065-1078. doi: 10.1111/cbdd.13963
41. [41]
  C.M. Avila, A.B. Lopes, A.S. Goncalves, et al., Eur. J. Med. Chem. 46 (2011) 1245-1253. doi: 10.1016/j.ejmech.2011.01.045
42. [42]
  R.G. Oliveira, F.S. Guerra, C.D.S. Mermelstein, et al., J. Enzyme Inhib. Med. Chem. 33 (2018) 1181-1193. doi: 10.1080/14756366.2018.1490732
43. [43]
  M. Uehata, T. Ishizaki, H. Satoh, et al., Nature 389 (1997) 990-994. doi: 10.1038/40187
44. [44]
  M. Arita, T. Saito, H. Okuda, et al., Yoshitomi Pharmaceutical Industries Ltd., Patent, US19940204211, 1992.
45. [45]
  M. Dietrich, H.P. Hartung, P. Albrecht, Neurol. Neuroimmunol. Neuroinflamm. 8 (2021) e976. doi: 10.1212/nxi.0000000000000976
46. [46]
  S. Li, D. Wei, Z. Mao, et al., Bioorg. Chem. 73 (2017) 63-75. doi: 10.1016/j.bioorg.2017.05.010
47. [47]
  Y. Yao, R. Li, X. Liu, et al., Molecules 22 (2017) 1766. doi: 10.3390/molecules22101766
48. [48]
  L. Gong, J. Peng, L. Fang, et al., Molecules 17 (2012) 5935-5944. doi: 10.3390/molecules17055935
49. [49]
  T.Y. Yuan, Y.C. Chen, H.F. Zhang, et al., Acta Pharmacol. Sin. 37 (2016) 604-616. doi: 10.1038/aps.2015.161
50. [50]
  A.D. Hobson, R.A. Judge, A.L. Aguirre, et al., J. Med. Chem. 61 (2018) 11074-11100. doi: 10.1021/acs.jmedchem.8b01098
51. [51]
  Z. Hu, C. Wang, D. Sitkoff, et al., Bioorg. Med. Chem. Lett. 30 (2020) 127474. doi: 10.1016/j.bmcl.2020.127474
52. [52]
  Y. Sun, Y. Li, Z. Miao, et al., Bioorg. Med. Chem. Lett. 45 (2021) 128138. doi: 10.1016/j.bmcl.2021.128138
53. [53]
  H. Gao, C. Marhefka, M.D. Jacobs, et al., Bioorg. Med. Chem. Lett. 28 (2018) 2616-2621. doi: 10.1016/j.bmcl.2018.06.043
54. [54]
  U.K. Bandarage, J. Cao, J.H. Come, et al., Bioorg. Med. Chem. Lett. 28 (2018) 2622-2626. doi: 10.1016/j.bmcl.2018.06.040
55. [55]
  U.K. Bandarage, J. Court, H. Gao, et al., Bioorg. Med. Chem. Lett. 33 (2021) 127721. doi: 10.1016/j.bmcl.2020.127721
56. [56]
  S. Ma, L. Wang, B. Ouyang, et al., Bioorg. Med. Chem. 28 (2020) 115683. doi: 10.1016/j.bmc.2020.115683
57. [57]
  L. Wang, B. Ouyang, M. Fan, et al., Iran. J. Pharm. Res. 20 (2021) 121-131.
58. [58]
  L. Wang, J. Qi, M. Fan, L. Yao, Chem. Biol. Drug Des. 98 (2021) 969-978. doi: 10.1111/cbdd.13961
59. [59]
  R. Pireddu, K.D. Forinash, N.N. Sun, et al., Medchemcomm 3 (2012) 699-709. doi: 10.1039/c2md00320a
60. [60]
  Y. Feng, Y. Yin, A. Weiser, et al., J. Med. Chem. 51 (2008) 6642-6645. doi: 10.1021/jm800986w
61. [61]
  Y. Feng, P. Lograsso, T. Bannister, et al., Patent, WO2008US13844, 2009.
62. [62]
  J. Pan, Y. Yin, L. Zhao, Y. Feng, Bioorg. Med. Chem. 27 (2019) 1382-1390. doi: 10.1016/j.bmc.2019.02.047
63. [63]
  J. Green, J. Cao, U.K. Bandarage, et al., J. Med. Chem. 58 (2015) 5028-5037. doi: 10.1021/acs.jmedchem.5b00424
64. [64]
  Z. Hu, C. Wang, P.W. Glunz, et al., Bioorg. Med. Chem. Lett. 30 (2020) 127495. doi: 10.1016/j.bmcl.2020.127495
65. [65]
  Z. Miao, Y.M. Sun, L.Y. Zhao, et al., Bioorg. Med. Chem. Lett. 30 (2020) 126966. doi: 10.1016/j.bmcl.2020.126966
66. [66]
  Y. Yin, L. Lin, C. Ruiz, et al., Bioorg. Med. Chem. Lett. 19 (2009) 6686-6690. doi: 10.1016/j.bmcl.2009.09.115
67. [67]
  R.A. Judge, A. Vasudevan, V.E. Scott, et al., Chembiochem 19 (2018) 613-621. doi: 10.1002/cbic.201700547
68. [68]
  E.H. Sessions, Y. Yin, T.D. Bannister, et al., Bioorg. Med. Chem. Lett. 18 (2008) 6390-6393. doi: 10.1016/j.bmcl.2008.10.095
69. [69]
  Y. Feng, T. Chen Yen, H. Sessions, et al., Patent, WO2011050245 (A1), 2011.
70. [70]
  M.A. Delong, J. Sturdivant, S.M. Royalty, et al., Invest. Ophthalmol. Vis. Sci. 50 (2009) 4058.
71. [71]
  M.A. deLong, J. Yingling, C.W. Lin, et al., Invest. Ophthalmol. Vis. Sci. 53 (2012) 3867.
72. [72]
  J.M. Sturdivant, S.M. Royalty, C.W. Lin, et al., Bioorg. Med. Chem. Lett. 26 (2016) 2475-2480. doi: 10.1016/j.bmcl.2016.03.104
73. [73]
  S.M. Hoy, Drugs 78 (2018) 389-396. doi: 10.1007/s40265-018-0877-7
74. [74]
  C.R. Hsu, Y.H. Chen, C.P. Liu, et al., Invest. Ophthalmol. Vis. Sci. 60 (2019) 624-633. doi: 10.1167/iovs.18-25252
75. [75]
  C.M. Tu, C.P. Liu, C.H. Chen, et al., Invest. Ophthalmol. Vis. Sci. 60 (2019) 3768. doi: 10.1167/iovs.18-26286
76. [76]
  S. Kesar, S. Paliwal, P. Mishra, et al., ACS Med. Chem. Lett. 11 (2020) 1694-1703. doi: 10.1021/acsmedchemlett.0c00126
77. [77]
  D. Domokos, F. Fulop, G. Falkay, R. Gaspar, Bioorg. Med. Chem. Lett. 28 (2018) 466-469. doi: 10.1016/j.bmcl.2017.12.017
78. [78]
  L. Zhao, Y. Li, Y. Wang, et al., J. Med. Chem. 62 (2019) 10691-10710. doi: 10.1021/acs.jmedchem.9b01143
79. [79]
  K.S. Oh, B.K. Oh, C.H. Park, et al., Eur. J. Pharmacol. 702 (2013) 218-226. doi: 10.1016/j.ejphar.2013.01.027
80. [80]
  V. Abbhi, L. Saini, S. Mishra, et al., Bioorg. Med. Chem. 25 (2017) 6071-6085. doi: 10.1016/j.bmc.2017.09.045
81. [81]
  E. Oshida, Y. Matsumoto, K. Arai, Clin. Ophthalmol. 4 (2010) 653-660.
82. [82]
  A. Izzotti, A. Bagnis, S.C. Sacca, Mutat. Res. 612 (2006) 105-114. doi: 10.1016/j.mrrev.2005.11.001
83. [83]
  J. Voller, L. Zahajska, L. Plihalova, et al., Bioorg. Chem. 90 (2019) 103005. doi: 10.1016/j.bioorg.2019.103005
84. [84]
  S. Li, N. Ai, M. Shen, et al., Cell Death Dis. 3 (2017) 17051. doi: 10.1038/cddiscovery.2017.51
85. [85]
  T. Skaria, E. Bachli, G. Schoedon, Cell Adhes. Migr. 11 (2017) 24-38. doi: 10.1080/19336918.2016.1178449
86. [86]
  M. Corada, M. Mariotti, G. Thurston, et al., Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 9815-9820. doi: 10.1073/pnas.96.17.9815
87. [87]
  T. Ladduwahetty, M.R. Lee, M.C. Maillard, et al., J. Med. Chem. 65 (2022) 9819-9845. doi: 10.1021/acs.jmedchem.2c00474
88. [88]
  Y.D. Zhao, L. Cai, M.K. Mirza, et al., Am. J. Pathol. 180 (2012) 2268-2275. doi: 10.1016/j.ajpath.2012.02.016
89. [89]
  N. Dayal, C.G. Mikek, D. Hernandez, et al., Eur. J. Med. Chem. 180 (2019) 449-456. doi: 10.1016/j.ejmech.2019.06.089
90. [90]
  W. Liu, Y. Xu, X. Li, et al., Chin. Chem. Lett. 32 (2021) 2322-2326. doi: 10.1016/j.cclet.2021.01.045
91. [91]
  S. Neidle, J. Med. Chem. 59 (2016) 5987-6011. doi: 10.1021/acs.jmedchem.5b01835
92. [92]
  D. Verga, C.H. N'Guyen, M. Dakir, et al., J. Med. Chem. 61 (2018) 10502-10518. doi: 10.1021/acs.jmedchem.8b01023
93. [93]
  C.J. Lord, A. Ashworth, Science 355 (2017) 1152-1158. doi: 10.1126/science.aam7344
94. [94]
  A.A. Antolin, J. Mestres, ACS Omega 3 (2018) 12707-12712. doi: 10.1021/acsomega.8b02337
95. [95]
  R. Pellicciari, E. Camaioni, G. Costantino, et al., Chemmedchem 3 (2008) 914-923. doi: 10.1002/cmdc.200800010
96. [96]
  H. Chen, Y. Lin, M. Han, et al., J. Pharm. Biomed. Anal. 52 (2010) 242-248. doi: 10.1016/j.jpba.2009.12.028
97. [97]
  A. Gaulton, A. Hersey, M. Nowotka, et al., Nucleic Acids Res. 45 (2017) D945-D954. doi: 10.1093/nar/gkw1074
98. [98]
  J.J. O'Shea, D.M. Schwartz, A.V. Villarino, et al., Annu. Rev. Med. 66 (2015) 311-328. doi: 10.1146/annurev-med-051113-024537
99. [99]
  D.M. Schwartz, Y. Kanno, A. Villarino, et al., Nat. Rev. Drug Discov. 17 (2017) 78.
100. [100]
  L.M. Mathias, W. Stohl, Expert Opin. Ther. Targets 24 (2020) 1283-1302. doi: 10.1080/14728222.2020.1832464
101. [101]
  M. Dulak-Lis, A. Bujak, K. Gala, et al., J. Pharmacol. Sci. 145 (2021) 340-348. doi: 10.1016/j.jphs.2021.02.002
102. [102]
  R.A. Stirzaker, P.S. Biswas, S. Gupta, et al., Lupus 21 (2012) 656-661. doi: 10.1177/0961203312436862
103. [103]
  P.S. Biswas, S. Gupta, E. Chang, et al., J. Clin. Invest. 120 (2010) 3280-3295. doi: 10.1172/JCI42856
104. [104]
  M. Okamoto, K. Takayama, T. Shimizu, et al., Bioorg. Med. Chem. 18 (2010) 2728-2734. doi: 10.1016/j.bmc.2010.02.018
105. [105]
  T. Usui, M. Okada, Y. Hara, H. Yamawaki, Hypertension 60 (2012) 1031-1039. doi: 10.1161/HYPERTENSIONAHA.112.200337
106. [106]
  Y.H. Chen, W.Y. Lin, Y.C. Huang, et al., Invest. Ophthalmol. Vis. Sci. 62 (2021) 12.
107. [107]
  H. Alrabiah, A.A. Kadi, M.W. Attwa, G.A.E. Mostafa, Chem. Cent. J. 12 (2018) 47. doi: 10.1186/s13065-018-0414-5
108. [108]
  A. Bonardi, C.T. Supuran, Expert Opin. Ther. Pat. 29 (2019) 753-759. doi: 10.1080/13543776.2019.1658743
109. [109]
  A. Delong Mitchell, M. Sturdivant Jill, M. Royalty Susan, Aerie Pharmaceuticals Inc., Patent, US2018244666A1, 2018.
110. [110]
  T.T. Ashburn, K.B. Thor, Nat. Rev. Drug Discov. 3 (2004) 673-683. doi: 10.1038/nrd1468
111. [111]
  S. Singhal, J. Mehta, R. Desikan, et al., N. Engl. J. Med. 341 (1999) 1565-1571. doi: 10.1056/NEJM199911183412102
112. [112]
  S. Pushpakom, F. Iorio, P.A. Eyers, et al., Nat. Rev. Drug Discov. 18 (2019) 41-58. doi: 10.1038/nrd.2018.168
113. [113]
  F. Iorio, R. Bosotti, E. Scacheri, et al., Proc. Natl. Acad. Sci. U. S. A. 107 (2010) 14621-14626. doi: 10.1073/pnas.1000138107
114. [114]
  R. Gunther, A. Balck, J.C. Koch, et al., Front. Pharmacol. 8 (2017) 17.
115. [115]
  L. Tonges, R. Gunther, M. Suhr, et al., Glia 62 (2014) 217-232. doi: 10.1002/glia.22601
116. [116]
  A. OzdemIr, M. Ark, Turk. J. Biol. 45 (2021) 35-45. doi: 10.3906/biy-2004-12
117. [117]
  T.F. Borin, A.S. Arbab, G.B. Gelaleti, et al., J. Pineal Res. 60 (2016) 3-15. doi: 10.1111/jpi.12270
118. [118]
  Y. Meng, Z. Ren, F. Xu, et al., Stem Cell Rep. 11 (2018) 1347-1356. doi: 10.1016/j.stemcr.2018.10.023
119. [119]
  Y. Zhang, J. Xu, Z. Ren, et al., Stem Cell Res. Ther. 12 (2021) 1-12. doi: 10.1186/s13287-020-02006-w
120. [120]
  C. Long, W.C. Luo, H.Y. Zhou, et al., Chin. Chem. Lett. 27 (2016) 247-250. doi: 10.1016/j.cclet.2015.10.005
121. [121]
  C.L. Xie, D. Zhang, K.Q. Guo, et al., Chin. Chem. Lett. 33 (2022) 2057-2059. doi: 10.1016/j.cclet.2021.09.073
122. [122]
  H. Wang, X. Bai, Y. Huang, et al., Chin. Chem. Lett. 34 (2023) 107671. doi: 10.1016/j.cclet.2022.07.014
123. [123]
  H. Arya, S.B. Syed, S.S. Singh, et al., Interdiscip. Sci. Comput. Life Sci. 10 (2018) 792-804. doi: 10.1007/s12539-017-0243-6
124. [124]
  H. Arya, C.S. Yadav, S.Y. Lin, et al., J. Biomol. Struct. Dyn. 38 (2020) 3563-3577. doi: 10.1080/07391102.2019.1664326
125. [125]
  H. Arya, M.S. Coumar, J. Mol. Model. 26 (2020) 249. doi: 10.5958/0974-4576.2020.00043.2
126. [126]
  Y. Amen, Q. Zhu, H.B. Tran, et al., J. Nat. Med. 71 (2017) 380-388. doi: 10.1007/s11418-016-1069-y
127. [127]
  J. Liu, Y. Lu, G. Li, et al., J. Biomol. Struct. Dyn. 39 (2021) 379-394. doi: 10.1080/07391102.2020.1714484
128. [128]
  G.M. Yang, J. Sun, Y. Pan, et al., Fitoterapia 124 (2018) 58-65. doi: 10.1016/j.fitote.2017.10.020
129. [129]
  J.N. Wang, H.J. Zhang, J.Q. Li, et al., J. Nat. Prod. 81 (2018) 949-956. doi: 10.1021/acs.jnatprod.7b01058
130. [130]
  Y.J. Jiang, D.S. Zhang, H.J. Zhang, et al., J. Nat. Prod. 81 (2018) 2120-2124. doi: 10.1021/acs.jnatprod.8b00544
131. [131]
  S.M. Ezzat, M.M. Okba, M.I. Ezzat, et al., Evid. Based Complement. Alternat. Med. 2019 (2019) 4341592.
132. [132]
  M. Nimgampalle, H.N. Banavath, H. Chakravarthy, et al., J. Biomol. Struct. Dyn. 38 (2020) 4669-4686. doi: 10.1080/07391102.2019.1686066
133. [133]
  Y. Amen, Q. Zhu, H.B. Tran, et al., Nat. Prod. Res. 32 (2018) 1955-1959. doi: 10.1080/14786419.2017.1354183
134. [134]
  Z. Xu, Z. Hu, H. Xu, et al., Exp. Cell Res. 411 (2022) 113008. doi: 10.1016/j.yexcr.2022.113008
135. [135]
  Y. Zhou, P.J. Little, S. Xu, D. Kamato, Molecules 26 (2021) 2320. doi: 10.3390/molecules26082320
136. [136]
  W. Liu, F. Qin, F. Wu, et al., Phytomedicine 69 (2020) 153193. doi: 10.1016/j.phymed.2020.153193
137. [137]
  A. Shu, Q. Du, J. Chen, et al., Chem. Biol. Interact. 348 (2021) 109625. doi: 10.1016/j.cbi.2021.109625
138. [138]
  W. Cao, R. Tian, R. Pan, et al., Bioengineered 13 (2022) 8643-8656. doi: 10.1080/21655979.2022.2054205
139. [139]
  X. Cheng, J. Zhang, Z. Chen, Evid. Based Complement. Alternat. Med. 2017 (2017) 5389272.
140. [140]
  X.Q. Sun, S. Chen, L.F. Wang, Z.W. Chen, J. Pharm. Pharmacol. 70 (2018) 1713-1722. doi: 10.1111/jphp.13016
141. [141]
  Y.T. Tseng, W.J. Lin, W.H. Chang, Y.C. Lo, Phytother. Res. 33 (2019) 690-701. doi: 10.1002/ptr.6259
142. [142]
  Z. Wei, Y. Xue, Y. Xue, et al., J. Pharmacol. Sci. 147 (2021) 72-80. doi: 10.1016/j.jphs.2021.05.006
143. [143]
  J. Yu, C. Zhu, J. Yin, et al., Drug Des. Devel. Ther. 14 (2020) 361-370. doi: 10.2147/dddt.s234262
144. [144]
  Y. Wang, Z. Shou, H. Fan, et al., Biosci. Rep. 39 (2019) BSR20182297. doi: 10.1042/BSR20182297
145. [145]
  Z. Zhang, L. Nong, M. Chen, et al., Acta Biochim. Biophys. Sin. 52 (2020) 1007-1015. doi: 10.1093/abbs/gmaa075
146. [146]
  Y. Zhao, J. Xu, Inflammation 43 (2020) 1476-1487. doi: 10.1007/s10753-020-01225-w
147. [147]
  J. Chen, W. Shi, Y. Xu, et al., Drug Des. Devel. Ther. 82 (2021) 553-561. doi: 10.1002/ddr.21773
148. [148]
  X. Wang, D. Hou, W. Dai, et al., Mol. Inf. 35 (2016) 262-267. doi: 10.1002/minf.201501022
149. [149]
  Z. Gu, T. Yan, F. Yan, J. Mol. Recognit. 33 (2020) e2835. doi: 10.1002/jmr.2835
150. [150]
  S. Zhao, J. Li, F. Wang, et al., Chin. Chem. Lett. 31 (2020) 1147-1152. doi: 10.1109/ispec50848.2020.9351076
151. [151]
  Q. Zhu, M. Saeed, R. Song, et al., Chin. Chem. Lett. 31 (2020) 1051-1059. doi: 10.1016/j.cclet.2019.12.002
152. [152]
  H. Zeng, Y. Qi, Z. Zhang, et al., Chin. Chem. Lett. 32 (2021) 1857-1868. doi: 10.1016/j.cclet.2021.01.014
153. [153]
  K. Thapa Magar, G.F. Boafo, X. Li, et al., Chin. Chem. Lett. 33 (2022) 587-596. doi: 10.1016/j.cclet.2021.08.020
154. [154]
  P. Wang, Y. Wang, P. Li, et al., Chin. Chem. Lett. 34 (2023) 107691. doi: 10.1016/j.cclet.2022.07.034
155. [155]
  N.D. Sheybani, H. Yang, Chin. Chem. Lett. 28 (2017) 1817-1821. doi: 10.1016/j.cclet.2017.07.022
156. [156]
  H. Zhu, J. Yu, J. Ye, et al., Chin. Chem. Lett. 34 (2023) 107648. doi: 10.1016/j.cclet.2022.06.071
157. [157]
  R. Liu, C. Luo, Z. Pang, et al., Chin. Chem. Lett. 34 (2023) 107518. doi: 10.1016/j.cclet.2022.05.032
158. [158]
  Y. Gao, Y. Gao, Y. Ding, et al., Chin. Chem. Lett. 32 (2021) 949-953. doi: 10.1016/j.cclet.2020.08.010
159. [159]
  S. Okimoto, S. Kuroda, H. Tashiro, et al., Hepatol. Res. 49 (2019) 663-675. doi: 10.1111/hepr.13317
160. [160]
  S. Klein, F. Frohn, F. Magdaleno, et al., Sci. Rep. 9 (2019) 2256. doi: 10.1038/s41598-019-38678-5
161. [161]
  H. Yin, L. Chen, B. Yang, et al., Org. Biomol. Chem. 15 (2017) 4336-4343. doi: 10.1039/C7OB00547D
162. [162]
  T.A. Al-Hilal, M.A. Hossain, A. Alobaida, et al., J. Control. Release 334 (2021) 237-247. doi: 10.1016/j.jconrel.2021.04.030
163. [163]
  K. Matsuo, S. Thayyil, M. Kawaguchi, et al., Chem. Commun. 57 (2021) 12500-12503. doi: 10.1039/d1cc04905d
1. [1]
  Ping Sun , Yuanqin Huang , Shunhong Chen , Xining Ma , Zhaokai Yang , Jian Wu . Indole derivatives as agrochemicals: An overview. Chinese Chemical Letters, 2024, 35(7): 109005-. doi: 10.1016/j.cclet.2023.109005
2. [2]
  Jia Chen , Yun Liu , Zerong Long , Yan Li , Hongdeng Qiu . Colorimetric detection of α-glucosidase activity using Ni-CeO₂ nanorods and its application to potential natural inhibitor screening. Chinese Chemical Letters, 2024, 35(9): 109463-. doi: 10.1016/j.cclet.2023.109463
3. [3]
  Yao HUANG , Yingshu WU , Zhichun BAO , Yue HUANG , Shangfeng TANG , Ruixue LIU , Yancheng LIU , Hong LIANG . Copper complexes of anthrahydrazone bearing pyridyl side chain: Synthesis, crystal structure, anticancer activity, and DNA binding. Chinese Journal of Inorganic Chemistry, 2025, 41(1): 213-224. doi: 10.11862/CJIC.20240359
4. [4]
  Jia JI , Zhaoyang GUO , Wenni LEI , Jiawei ZHENG , Haorong QIN , Jiahong YAN , Yinling HOU , Xiaoyan XIN , Wenmin WANG . Two dinuclear Gd(Ⅲ)-based complexes constructed by a multidentate diacylhydrazone ligand: Crystal structure, magnetocaloric effect, and biological activity. Chinese Journal of Inorganic Chemistry, 2025, 41(4): 761-772. doi: 10.11862/CJIC.20240344
5. [5]
  Yingyue ZHANG , Liuqing KANG , Yating YANG , Xiaofen GUAN , Wenmin WANG . Crystal structure and antibacterial activity of two Gd₂ complexes based on polydentate Schiff-base ligands. Chinese Journal of Inorganic Chemistry, 2025, 41(9): 1867-1877. doi: 10.11862/CJIC.20250100
6. [6]
  Jian Song , Shenghui Wang , Qiuge Liu , Xiao Wang , Shuo Yuan , Hongmin Liu , Saiyang Zhang . N-Benzyl arylamide derivatives as novel and potent tubulin polymerization inhibitors against gastric cancers: Design, structure–activity relationships and biological evaluations. Chinese Chemical Letters, 2025, 36(2): 109678-. doi: 10.1016/j.cclet.2024.109678
7. [7]
  Peipei CUI , Yawen ZHENG , Pan LI , Peiyan GUAN , Zhaohong QIAN . Praseodymium-organic framework with 4, 4′-oxybis(benzoic acid): Rare broken layer structure, antibacterial activity, and sensing for Cd²⁺ ions. Chinese Journal of Inorganic Chemistry, 2025, 41(8): 1641-1649. doi: 10.11862/CJIC.20250152
8. [8]
  Jiarong ZHU , Xiaohua ZHANG , Xinting XIONG , Xuliang NIE , Xiuying SONG , Miaomiao ZHANG , Dayong PENG , Xiuguang YI . Crystal structure, Hirshfeld surface analysis, and antifungal activity of five complexes based on 2,5-bis(carboxymethoxy)terephthalic acid. Chinese Journal of Inorganic Chemistry, 2025, 41(11): 2358-2370. doi: 10.11862/CJIC.20250150
9. [9]
  Guangyao Wang , Zhitong Xu , Ye Qi , Yueguang Fang , Guiling Ning , Junwei Ye . Electrospun nanofibrous membranes with antimicrobial activity for air filtration. Chinese Chemical Letters, 2024, 35(10): 109503-. doi: 10.1016/j.cclet.2024.109503
10. [10]
  Ting Li , Xinxin Zheng , Lejing Qu , Yuanyuan Ou , Sai Qiao , Xue Zhao , Yajun Zhang , Xinfeng Zhao , Qian Li . A chromatographic method for pursuing potential GPCR ligands with the capacity to characterize their intrinsic activities of regulating downstream signaling pathway. Chinese Chemical Letters, 2024, 35(10): 109792-. doi: 10.1016/j.cclet.2024.109792
11. [11]
  Zhihao HE , Jiafu DING , Yunjie WANG , Xin SU . First-principles study on the structure-property relationship of AlX and InX (X=N, P, As, Sb). Chinese Journal of Inorganic Chemistry, 2025, 41(5): 1007-1019. doi: 10.11862/CJIC.20240390
12. [12]
  Ting Wang , Xin Yu , Yaqiang Xie . Unlocking stability: Preserving activity of biomimetic catalysts with covalent organic framework cladding. Chinese Chemical Letters, 2024, 35(6): 109320-. doi: 10.1016/j.cclet.2023.109320
13. [13]
  Fangping Yang , Jin Shi , Yuansong Wei , Qing Gao , Jingrui Shen , Lichen Yin , Haoyu Tang . Mixed-charge glycopolypeptides as antibacterial coatings with long-term activity. Chinese Chemical Letters, 2025, 36(2): 109746-. doi: 10.1016/j.cclet.2024.109746
14. [14]
  Chong Liu , Ling Li , Jiahui Gao , Yanwei Li , Nazhen Zhang , Jing Zang , Cong Liu , Zhaopei Guo , Yanhui Li , Huayu Tian . The study of antibacterial activity of cationic poly(β-amino ester) regulating by amphiphilic balance. Chinese Chemical Letters, 2025, 36(2): 110118-. doi: 10.1016/j.cclet.2024.110118
15. [15]
  Di ZHANG , Tianxiang XIE , Xu HE , Wanyu WEI , Qi FAN , Jie QIAO , Gang JIN , Ningbo LI . Construction and antitumor activity of pH/GSH dual-responsive magnetic nanodrug. Chinese Journal of Inorganic Chemistry, 2025, 41(4): 786-796. doi: 10.11862/CJIC.20240329
16. [16]
  Yuanyuan Zeng , Fang Liu , Jun Wang , Bianfei Shao , Tao He , Zhongzheng Xiang , Yan Wang , Shunyao Zhu , Tian Yang , Siting Yu , Changyang Gong , Lei Liu . Fisetin micelles precisely exhibit a radiosensitization effect by inhibiting PDGFRβ/STAT1/STAT3/Bcl-2 signaling pathway in tumor. Chinese Chemical Letters, 2025, 36(2): 109734-. doi: 10.1016/j.cclet.2024.109734
17. [17]
  Yujie Zhu , Ruijianghan Shi , Weitong Lu , Yang Chen , Yunfeng Lin , Sirong Shi . Tetrahedral framework nucleic acids prevent epithelial-mesenchymal transition-mediated diabetic fibrosis by targeting the Wnt/β-catenin signaling pathway. Chinese Chemical Letters, 2025, 36(5): 110140-. doi: 10.1016/j.cclet.2024.110140
18. [18]
  Xiangyuan Zhao , Jinjin Wang , Jinzhao Kang , Xiaomei Wang , Hong Yu , Cheng-Feng Du . Ni nanoparticles anchoring on vacuum treated Mo2TiC2Tx MXene for enhanced hydrogen evolution activity. Chinese Journal of Structural Chemistry, 2023, 42(10): 100159-100159. doi: 10.1016/j.cjsc.2023.100159
19. [19]
  Xinyi Hu , Riguang Zhang , Zhao Jiang . Depositing the PtNi nanoparticles on niobium oxide to enhance the activity and CO-tolerance for alkaline methanol electrooxidation. Chinese Journal of Structural Chemistry, 2023, 42(11): 100157-100157. doi: 10.1016/j.cjsc.2023.100157
20. [20]
  Anqiu LIU , Long LIN , Dezhi ZHANG , Junyu LEI , Kefeng WANG , Wei ZHANG , Junpeng ZHUANG , Haijun HAO . Synthesis, structures, and catalytic activity of aluminum and zinc complexes chelated by 2-((2,6-dimethylphenyl)amino)ethanolate. Chinese Journal of Inorganic Chemistry, 2024, 40(4): 791-798. doi: 10.11862/CJIC.20230424

Get Citation

PDF

XML

Metrics

PDF Downloads(10)
Abstract views(1218)
HTML views(59)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142